Active ingredient
Cabergoline
12 finished FDA listings contain Cabergoline as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CABERGOLINE
- Dosage forms
- Tablet
- Routes
- Oral
- Manufacturers / labelers
- 9
- Strengths listed
- .5 mg/1
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 47579
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 020664 | PFIZER | 1996-12-23 | 1 |
| ANDA 076310 | STRIDES PHARMA INTL | 2005-12-29 | 3 |
| ANDA 077750 | IVAX SUB TEVA PHARMS | 2007-03-07 | 2 |
| ANDA 204735 | INGENUS PHARMS LLC | 2018-08-01 | 2 |
| ANDA 218618 | AMNEAL | 2024-06-25 | 2 |
| ANDA 218109 | SOMERSET THERAPS LLC | 2024-09-09 | 1 |
| ANDA 220309 | RENATA | 2026-06-15 | 1 |
Official labeling on DailyMed
- CABERGOLINE TABLET [CRANBURY PHARMACEUTICALS, LLC] · version 4 · 2026-08-03
- CABERGOLINE TABLET [MYLAN PHARMACEUTICALS INC.] · version 12 · 2026-07-01
- CABERGOLINE TABLET [A-S MEDICATION SOLUTIONS] · version 10 · 2026-03-20
- CABERGOLINE TABLET [SOLA PHARMACEUTICALS, LLC] · version 4 · 2025-12-09
- CABERGOLINE TABLET [INGENUS PHARMACEUTICALS, LLC] · version 12 · 2025-11-17
- CABERGOLINE TABLET [A-S MEDICATION SOLUTIONS] · version 1 · 2025-08-28
- CABERGOLINE TABLET [TEVA PHARMACEUTICALS USA, INC.] · version 21 · 2025-07-21
- CABERGOLINE TABLET [SOMERSET THERAPEUTICS, LLC] · version 4 · 2024-11-18
- CABERGOLINE TABLET [AMNEAL PHARMACEUTICALS NY LLC] · version 1 · 2024-10-04
- CABERGOLINE TABLET [A-S MEDICATION SOLUTIONS] · version 1 · 2023-08-29
- CABERGOLINE TABLET [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.] · version 2 · 2023-07-31
- CABERGOLINE TABLET [A-S MEDICATION SOLUTIONS] · version 6 · 2023-04-14
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.